Proteolysis Targeting Chimera Protac Market to Reach USD 5 Billion by 2035, Riding on 13.1% CAGR
The Proteolysis Targeting Chimera PROTAC Market is emerging as one of the most promising segments in next-generation drug discovery, offering a revolutionary approach to degrading disease-causing proteins rather than simply inhibiting them. According to recent market analysis, the market size was valued at USD 1,300 Million in 2024 and is projected to reach USD 1,500 … Read more